- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type in United Kingdom
Total 4116 results
-
University Hospital Southampton NHS Foundation...CompletedFollicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Peripheral T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Classical Hodgkin Lymphoma | Small Lymphocytic Lymphoma | High-grade B-cell Lymphoma | Nodular Lymphocyte... and other conditionsUnited Kingdom
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompleted
-
Kevin Cooper MDNational Cancer Institute (NCI)CompletedRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides/Sezary Syndrome | Stage I Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IA Mycosis Fungoides/Sezary Syndrome | Stage IB Mycosis Fungoides/Sezary Syndrome | Stage II Cutaneous T-cell Non-Hodgkin Lymphoma | Stage IIA Mycosis...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation RecipientUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMycosis Fungoides | Sezary Syndrome | Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI); AbbVieUnknownUnresectable Solid Neoplasm | Recurrent Solid Neoplasm | Refractory Mantle Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Advanced Solid Neoplasm | T-Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminated
-
PeplinCompletedSuperficial Basal Cell CarcinomaUnited States
-
SirnaomicsAmarex Clinical ResearchCompletedBasal Cell CarcinomaUnited States
-
SkinJect, Inc.Terminated
-
Austin Institute for Clinical ResearchRecruitingSuperficial Basal Cell CarcinomaUnited States
-
Brian GastmanActive, not recruitingBasal Cell Carcinoma of the Head and NeckUnited States
-
AiViva BioPharma, Inc.CompletedNodular Basal Cell Carcinoma | Superficial Basal Cell CarcinomaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumTerminatedAcute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia | Precursor T-Cell Lymphoblastic LeukemiaUnited States, Australia
-
Boryung Pharmaceutical Co., LtdActive, not recruitingFollicular Lymphoma | B Cell Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Small Lymphocytic LeukemiaKorea, Republic of, United States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
Thomas Jefferson UniversityAdvanced AestheticsUnknownBasal Cell CarcinomaUnited States
-
Innate PharmaActive, not recruitingLymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary SyndromeUnited States, Spain, France, Italy, Belgium, Austria, Germany, Poland
-
Case Comprehensive Cancer CenterRecruitingBasal Cell CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingBasal Cell CarcinomaUnited States
-
Anne ChangNovartisCompletedBasal Cell CarcinomaUnited States
-
Yale UniversityNational Cancer Institute (NCI)Completed
-
Roswell Park Cancer InstituteCompletedPrimary Myelofibrosis | Polycythemia Vera | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma and other conditionsUnited States
-
Myeloid TherapeuticsSuspendedLymphoma, T-Cell, Cutaneous | Mycosis Fungoides | Lymphoma, T-Cell, Peripheral | Cell Therapy | Adoptive Cellular ImmunotherapyUnited States
-
Berg, LLCCompletedSuperficial Basal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBasal Cell CarcinomaUnited States
-
University of MiamiWithdrawn
-
Center for Biomedical Research, Inc.Completed
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedSkin Basal Cell CarcinomaUnited States
-
University of PittsburghRecruitingEczema | Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Atopic DermatitisUnited States
-
University of RochesterRochester Dermatologic SurgeryRecruitingBasal Cell CarcinomaUnited States
-
University of California, San DiegoMassachusetts General HospitalCompletedBasal Cell CarcinomaUnited States
-
Emory UniversityCompleted
-
Stanford UniversityMillennium Pharmaceuticals, Inc.WithdrawnLeukemia | Acute Lymphocytic LeukemiaUnited States
-
Prelude TherapeuticsBeiGeneRecruitingT-cell Lymphoma | Mantle Cell Lymphoma (MCL) | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | Richter's Syndrome | Aggressive B-Cell Non-Hodgkin's Lymphoma | Aggressive B-Cell NHLUnited States, Canada, Korea, Republic of, Australia, France, Poland, Italy, Germany, Switzerland, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.RecruitingAdvanced Basal Cell CarcinomaUnited States
-
Neotherix LimitedNAMSA; Innovate UK; Lorien Engineering Solutions (a division of GP Strategies... and other collaboratorsCompletedBasal Cell Carcinoma | Squamous Cell Carcinoma | Non-melanoma Skin CancerUnited Kingdom
-
Mayo ClinicGenentech, Inc.CompletedBasal Cell CarcinomaUnited States
-
Wake Forest UniversityCompletedBasal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States, Canada
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
Bristol-Myers SquibbWithdrawnLymphoma, Large-CellUnited States, France
-
National Cancer Institute (NCI)CompletedRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 | Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7United States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedLymphoma, T-Cell | Lymphoma, Extranodal NK-T-CellUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Biofrontera Bioscience GmbHActive, not recruitingSuperficial Basal Cell CarcinomaUnited States
-
Anne ChangNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedSkin Basal Cell CarcinomaUnited States